Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2008-11-06
2010-10-05
Chung, Susannah (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S364000, C514S378000, C544S098000, C546S207000, C546S208000, C548S240000
Reexamination Certificate
active
07807669
ABSTRACT:
Novel biaromatic compounds having the structural formula (I) below:are formulated into pharmaceutical compositions suited for administration in human or veterinary medicine (in dermatology, and also in the fields of cardiovascular diseases, immune diseases and/or diseases associated with lipid metabolism), or, alternatively, into cosmetic compositions.
REFERENCES:
patent: 6927228 (2005-08-01), Bernardon et al.
patent: 7157490 (2007-01-01), Colandrea et al.
patent: 7452878 (2008-11-01), Clary et al.
patent: 7625914 (2009-12-01), Clary et al.
patent: 2009/0012129 (2009-01-01), Boiteau et al.
patent: WO 0035864 (2000-06-01), None
patent: WO 01/21584 (2001-03-01), None
patent: WO 02/12210 (2002-02-01), None
Castanedo et al., “Solid-Phase Synthesis of Dual α4β1/α4β7 Integrin Antagonists: Two Scaffolds with Overlapping Pharmacophores”, Bioorganic & Medicinal Chemistry Letters, Oct. 2002, pp. 2913-2917, vol. 12, Elsevier Science Ltd.
Sircar et al., “Synthesis and SAR of N-benzoyl-L-Biphenylalanine Derivatives: Discovery of TR-14035, A Dual α4β7/α4β1 Integrin Antagonist”, Bioorganic & Medicinal Chemistry, Jun. 2002, pp. 2051-2066, vol. 10, Elsevier Science Ltd.
French Search Report corresponding to FR 02/14465, issued on Aug. 7, 2003, 3 pages.
International Search Report corresponding to PCT/EP 03/14861, issued on May 25, 2004, 5 pages.
Bouix-Peter Claire
Clary Laurence
Collette Pascal
Jomard Andre
Rivier Michel
Buchanan & Ingersoll & Rooney PC
Chung Susannah
Galderma Research & Development
LandOfFree
Biaromatic compounds which activate PPARγ type... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Biaromatic compounds which activate PPARγ type..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Biaromatic compounds which activate PPARγ type... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4174266